Funding for this research was provided by:
IBM Center for the Business of Government
Received: 31 March 2020
Accepted: 30 June 2020
First Online: 20 August 2020
Ethics approval and consent to participate
: The local ethics committee of the Medical University of Vienna approved the retrospective analysis of the imaging data for the study (approval number 1154/2014).
: Not applicable
: JH speaker fees: Boehringer-Ingelheim. SR consulting activities for contextflow GmbH. HP speakers fees: Boehringer-Ingelheim, Roche, Novartis, MSD, BMS, GSK, Chiesi, AstraZeneca; research support: Boehringer-Ingelheim. GL shareholder/co-founder contextflow GmbH; speaker fees: Roche, Siemens.